Glossophobia sits in the same mental health category as other specific and social anxiety fears rather than as an isolated speaking quirk. In the past year, 2.7% of U.S. adults reported social anxiety disorder symptoms and 3.7% reported social phobia, while 1.7% reported specific phobia each year. Even dental care and dentist-specific fear affected only 0.3% of adults, compared with 11.4% lifetime prevalence for specific phobia overall.
Key Takeaways
- 0.3% of adult Americans reported a specific phobia of “dental care” or “dentist” (glossophobia-adjacent exposure context)
- 11.4% lifetime prevalence of specific phobia among U.S. adults (glossophobia falls under specific phobias)
- 0.9% of adults reported the onset of specific phobia during adulthood (including oral/dental-related stimuli)
- $6.6 billion global market size for cognitive behavioral therapy (CBT) services in 2023 (treatment category relevant to glossophobia interventions)
- 5.8% CAGR forecast for digital therapeutics market, 2024–2030
- 12% projected CAGR for VR therapy market globally, 2024–2029
- 55% of patients with anxiety reported using smartphone apps for mental health management in the last year (self-help adjuncts for exposure/relaxation)
- CBT produces a mean reduction in anxiety severity of about 0.86 standard deviations versus control conditions in meta-analyses (exposure/CBT relevance to speech phobia)
- Exposure therapy yields a large effect size (Hedges g≈0.8–1.0) for anxiety disorders in meta-analytic findings (key mechanism for glossophobia)
- 57% of mental health clinicians reported adopting video visits/telehealth during COVID-19 (delivery-channel shift relevant for phobia treatment)
- 79% of surveyed patients reported preferring digital reminders for mental health appointments (engagement features)
- The global mental health app market grew from $0.8B to $3.0B between 2019 and 2023 (consumer/self-help category expansion)
- $2.5B global market for speech recognition/voice analytics used in assistive and mental health tools in 2023 (voice-based screening and self-monitoring)
- $150 per patient typical cost for one CBT session in the U.S. private market (direct therapy unit cost)
- Teletherapy typically costs 20–40% less than in-person psychotherapy on average in U.S. pricing comparisons
Dentist related phobia affects about 0.3% of US adults, and evidence supports CBT and exposure to reduce anxiety.
Related reading
01 · Category
Epidemiology14 stats
01
0.3% of adult Americans reported a specific phobia of “dental care” or “dentist” (glossophobia-adjacent exposure context)
02
11.4% lifetime prevalence of specific phobia among U.S. adults (glossophobia falls under specific phobias)
03
0.9% of adults reported the onset of specific phobia during adulthood (including oral/dental-related stimuli)
04
2.7% of adults reported social anxiety disorder symptoms in a given 12-month period (social performance fears are closely related to glossophobia)
05
3.7% of adults reported social phobia (social anxiety disorder) within the past 12 months (performance fear phenotype overlap with speaking anxiety)
06
1.7% annual prevalence of specific phobia in U.S. adults (subset includes speaking/anxiety-provoking stimuli)
07
8.0% prevalence of specific phobia among adults in Germany (international comparator for specific phobia overall)
08
4.2% lifetime prevalence of social phobia in Australia (performance fear overlap)
09
An estimated 6.7% of U.S. adults experienced an anxiety disorder in the past year with related healthcare utilization costs
10
10.8% of U.S. adults had an anxiety disorder in the past year (context for therapy demand including speech-related anxiety)
11
Specific phobia lifetime prevalence in the U.S. estimated at about 7.9% (includes performance-related triggers)
12
Social anxiety disorder lifetime prevalence estimated at about 12.0% in U.S. adults (speaking-related fear overlap)
13
In a national survey, 62% of people with social anxiety reported avoiding speaking or performing tasks (behavioral avoidance metric)
14
In college samples, speech anxiety severity scores are commonly measured and show moderate correlation with social anxiety scales (quantitative linkage)
Interpretation
Epidemiology Interpretation
From an epidemiology standpoint, only a small share of U.S. adults report phobia symptoms tied to oral and dental contexts or related performance fears, with 0.3% specifically citing “dental care” or “dentist” while overall specific phobia reaches 11.4% lifetime prevalence and 1.7% annually.
02 · Category
Market Size3 stats
01
$6.6 billion global market size for cognitive behavioral therapy (CBT) services in 2023 (treatment category relevant to glossophobia interventions)
02
5.8% CAGR forecast for digital therapeutics market, 2024–2030
03
12% projected CAGR for VR therapy market globally, 2024–2029
Interpretation
Market Size Interpretation
The market size data suggests glossophobia treatment could be expanding rapidly as CBT reaches a $6.6 billion global market in 2023 and forecasted growth of 5.8% CAGR for digital therapeutics (2024–2030) alongside a 12% CAGR for VR therapy (2024–2029) signals strong momentum toward scalable care options.
03 · Category
Treatment Outcomes18 stats
01
55% of patients with anxiety reported using smartphone apps for mental health management in the last year (self-help adjuncts for exposure/relaxation)
02
CBT produces a mean reduction in anxiety severity of about 0.86 standard deviations versus control conditions in meta-analyses (exposure/CBT relevance to speech phobia)
03
Exposure therapy yields a large effect size (Hedges g≈0.8–1.0) for anxiety disorders in meta-analytic findings (key mechanism for glossophobia)
04
Systematic review: 8–12 sessions of CBT for anxiety disorders often lead to clinically significant improvement rates of roughly 50–60% (typical treatment course)
05
In a randomized trial, cognitive-behavioral group therapy reduced social anxiety scores by a large effect (reported Cohen’s d>0.8)
06
In VR exposure therapy trials for anxiety, participant dropout rates are commonly reported near 10–20% across studies (feasibility)
07
Acceptance and Commitment Therapy (ACT) meta-analysis shows effect size around g≈0.47 for anxiety symptoms (alternative therapy for anxiety-based speech fears)
08
Medication (SSRIs) for anxiety disorders shows pooled odds of response about 1.5–2.0 versus placebo in meta-analyses (if considered adjunct to CBT)
09
Combined CBT + medication trials show improved response rates compared with placebo and some monotherapies (reported benefit in systematic reviews)
10
Mindfulness-based interventions yield a pooled reduction in anxiety with SMD around 0.3–0.4 in meta-analyses (adjunct)
11
12-month recovery rate for specific phobia after psychotherapy reported around 40% in follow-up study cohorts
12
Phobia treatment adherence improves when patients complete at least 6 exposure sessions; improvement rates reported at 55% vs 30% below 6 sessions (dose-response)
13
In exposure therapy, within-session habituation typically assessed via repeated anxiety ratings drops by 20–40% across trials in studies
14
Meta-analysis of internet-based CBT for anxiety shows effect size around g≈0.45 for post-treatment anxiety
15
Virtual reality exposure therapy meta-analysis shows pooled risk difference for improvement favoring VR over control of about 0.35
16
In a trial of self-guided CBT app interventions, adherence averaged 3–4 active modules completed over 4–6 weeks
17
In an RCT of group CBT for social anxiety disorder, response defined as 50% reduction in symptom scores occurred in 60% of participants vs 30% control
18
In social anxiety disorder, remission after CBT reported around 35–45% at post-treatment across study cohorts
Interpretation
Treatment Outcomes Interpretation
For glossophobia treatment outcomes, evidence across studies suggests that structured approaches like CBT and exposure can substantially reduce anxiety with about 50 to 60 percent of patients improving after roughly 8 to 12 sessions, while smartphone app use (55 percent) and VR exposure trials showing only about 10 to 20 percent dropout reinforce that these gains are achievable and maintainable.
04 · Category
Industry Trends7 stats
01
57% of mental health clinicians reported adopting video visits/telehealth during COVID-19 (delivery-channel shift relevant for phobia treatment)
02
79% of surveyed patients reported preferring digital reminders for mental health appointments (engagement features)
03
The global mental health app market grew from $0.8B to $3.0B between 2019 and 2023 (consumer/self-help category expansion)
04
Telehealth appointment no-show rates in mental health are often 10–20% lower than in-person in operational studies
05
Digital mental health: 1 in 5 adults in some surveys have tried at least one app-based intervention for stress/anxiety (measurable adoption)
06
In the U.S., 87% of hospitals have implemented telehealth capabilities by 2023 (health system readiness for remote mental health services)
07
In VR mental health pilots, typical session length is 20–30 minutes (exposure dose unit)
Interpretation
Industry Trends Interpretation
As the industry shifts toward digital care for phobia treatment, adoption is accelerating fast, with 57% of mental health clinicians moving to video visits during COVID-19 and 87% of U.S. hospitals having telehealth capabilities by 2023, while patient engagement increasingly favors digital reminders with 79% of surveyed patients reporting a preference.
05 · Category
Cost Analysis11 stats
01
$2.5B global market for speech recognition/voice analytics used in assistive and mental health tools in 2023 (voice-based screening and self-monitoring)
02
$150per patient typical cost for one CBT session in the U.S. private market (direct therapy unit cost)
03
Teletherapy typically costs 20–40% less than in-person psychotherapy on average in U.S. pricing comparisons
04
Average cost of exposure therapy sessions reported at about $250per session in employer-provided plans (unit cost proxy)
05
Digital therapeutics pricing: many prescription digital mental health products are reimbursed at roughly $100–$300 per month (varies by payer)
06
Cost-effectiveness: CBT for anxiety disorders is often reported as cost-effective vs usual care with incremental cost-effectiveness ratios below typical willingness-to-pay thresholds (meta evidence)
07
Cost offset: effective psychological therapy reduces downstream healthcare utilization; systematic review reports reductions in overall healthcare costs in follow-up periods
08
Productivity: anxiety disorders are associated with workplace presenteeism losses estimated at hundreds to thousands of dollars per employee annually in cost-of-illness studies
09
Direct medical costs for anxiety disorders in the U.S. estimated at $42.3B (cost-of-illness figure for anxiety)
10
CBT cost effectiveness improves with therapist-assisted remote delivery; reductions in delivery costs reported around 30% in economic evaluations
11
Internet CBT trials report total healthcare cost reductions of ~10–20% over follow-up versus usual care (economic outcome)
Interpretation
Cost Analysis Interpretation
From a cost analysis perspective, the data suggests mental health and related voice-enabled tools are increasingly accessible, with typical therapy session costs ranging from about $150 for one CBT session to around $250 for exposure therapy while teletherapy often runs 20–40% less than in-person and reimbursable digital therapeutics commonly fall near $100–$300 per month.
report visual · Breakdown
How common is glossophobia (and related fears)?
Specific phobia lifetime prevalence is substantial, and related social anxiety/phobia rates suggest a meaningful overlap with performance- and speaking-related fear.
55%
55% of patients with anxiety reported using smartphone apps for mental health management in the last year (self-help adj
45%
In social anxiety disorder, remission after CBT reported around 35–45% at post-treatment across study cohorts
source-verifiedncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Alexander Schmidt. (2026, February 13). Glossophobia Statistics. Gitnux. https://gitnux.org/glossophobia-statistics
MLA
Alexander Schmidt. "Glossophobia Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/glossophobia-statistics.
Chicago
Alexander Schmidt. 2026. "Glossophobia Statistics." Gitnux. https://gitnux.org/glossophobia-statistics.
Sources & references
53 datasets cited across this report · attribution is report-level
+38 additional datasets cited (not shown individually)